Eris Lifesciences Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported revenue was INR 4,038.02 million compared to INR 3,140.1 million a year ago. Net income was INR 654.18 million compared to INR 802.96 million a year ago. Basic earnings per share from continuing operations was INR 4.81 compared to INR 5.91 a year ago. Diluted earnings per share from continuing operations was INR 4.79 compared to INR 5.91 a year ago.
For the full year, revenue was INR 16,963.02 million compared to INR 13,731.37 million a year ago. Net income was INR 3,821.58 million compared to INR 4,061.13 million a year ago. Basic earnings per share from continuing operations was INR 28.1 compared to INR 29.89 a year ago. Diluted earnings per share from continuing operations was INR 28.07 compared to INR 29.88 a year ago.